FDA approves ViroSeq HIV-1 genotyping system.
D019380:Anti-HIV Agents / Q000627:therapeutic use; D018795:Device Approval; D005838:Genotype; D015658:HIV Infections / Q000175:diagnosis*; D015497:HIV-1 / Q000145:classification* / Q000235:genetics*; D006801:Humans; D025202:Molecular Diagnostic Techniques; D017422:Sequence Analysis, DNA / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents